Last reviewed · How we verify
Placebo (for vitamin D)
Placebo has no active pharmacological mechanism; it is an inert substance used as a control in clinical trials.
Placebo has no active pharmacological mechanism; it is an inert substance used as a control in clinical trials. Used for Control arm in vitamin D supplementation clinical trials.
At a glance
| Generic name | Placebo (for vitamin D) |
|---|---|
| Sponsor | Fondazione Policlinico Universitario Agostino Gemelli IRCCS |
| Modality | Small molecule |
| Therapeutic area | Nutritional/Metabolic |
| Phase | FDA-approved |
Mechanism of action
Placebo is a non-therapeutic agent administered in blinded studies to serve as a comparator against an active treatment. Any observed effects are attributable to the placebo effect—a psychobiological response driven by patient expectation and the clinical context rather than direct drug action. In this case, it is used as a control arm in vitamin D supplementation trials.
Approved indications
- Control arm in vitamin D supplementation clinical trials
Common side effects
Key clinical trials
- Toddler Biomarker of Nutrition Study (NA)
- Effect of Tirzepatide and Bimagrumab on Body Composition, Insulin Sensitivity, and Bone in Adults With Obesity (PHASE2)
- Acute Vitamin D Supplementation on Testosterone in Females (NA)
- Vitamin E Dosing Study (PHASE2)
- Effect of Vitamin D and Folic Acid on Mild Cognitive Impairment (NA)
- Vitamin D Supplementation During Pregnancy for Prevention of Asthma in Childhood (PHASE1)
- Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia (PHASE2)
- Effects of Vitamin D and Calcium on Hyperglycemia and Dyslipidemia in Patients Gestational Diabetes (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: